STSS - RARE DISEASES INFORMATICS PROGRAM (RDIP) SUPPORT

STSS - 罕见疾病信息学计划 (RDIP) 支持

基本信息

  • 批准号:
    10505184
  • 负责人:
  • 金额:
    $ 101.97万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-09-28 至 2022-09-27
  • 项目状态:
    已结题

项目摘要

Currently, there are about 7,000-10,000 known rare diseases that affect people in the US, yet only a few hundred (less than 5%) have a treatment and even fewer a cure. A rare disease is defined in US law (Orphan Drug Act (ODA) of 1983, Rare Diseases Act (RDA) of 2002) as a disease or condition that affects fewer than 200,000 people in the US. Most rare diseases affect far fewer patients than this, with most rare diseases affecting only a few hundreds to thousands of patients. Collectively, however, rare diseases are not rare at all, and in total are estimated to affect as many as 25-30 million patients in the US, making rare diseases a large public health consideration. Informatics plays an important role in rare disease research support and patient care. Given the large number of different rare diseases, each of which affects only a small number of patients, assessing the broad rare diseases research and healthcare landscape is challenging. In order to better understand the ongoing research, treatment and healthcare utilization, and diagnostic journey of patients with rare diseases, NCATS ORDR is seeking to create a rare disease-specific analytics platform that could enable more efficient and coordinated approaches to data collection, integration and analysis from diverse sources, such as the medical literature, NIH databases and healthcare systems data. This could include establishing an informatics platform infrastructure, development of machine-learning tools and methods to identify, collect, integrate and analyze such data, and dissemination of the findings to the rare diseases research and clinical communities to help identify and inform rare diseases research priorities. Initially, building an informatics infrastructure framework and performing smaller pilot projects would be prioritized, with the larger goal of building on this experience to gain greater understanding of rare diseases research and healthcare over a broader scope over time.
目前,在美国,大约有7000 - 10000种已知的罕见疾病影响着人们,但只有几百种(不到5%)有治疗方法,治愈的更少。美国法律(1983年的《孤儿药法案》(ODA)、2002年的《罕见病法案》(RDA))将罕见病定义为在美国影响不到20万人的疾病或病症。大多数罕见病影响的患者远少于此,大多数罕见病仅影响数百至数千名患者。然而,总的来说,罕见疾病一点也不罕见,估计总共影响美国多达2500万至3000万患者,使罕见疾病成为一个重要的公共卫生问题。 信息学在罕见病研究支持和患者护理中发挥着重要作用。鉴于大量不同的罕见病,每种疾病只影响少数患者,评估广泛的罕见病研究和医疗保健前景是具有挑战性的。为了更好地了解正在进行的研究,治疗和医疗保健利用,以及罕见病患者的诊断旅程,NCATS ORR正在寻求创建一个罕见病特定的分析平台,可以实现更有效和协调的方法来收集,整合和分析来自不同来源的数据,如医学文献,NIH数据库和医疗保健系统数据。这可能包括建立信息学平台基础设施,开发机器学习工具和方法来识别、收集、整合和分析此类数据,以及将研究结果传播给罕见病研究和临床社区,以帮助识别和告知罕见病研究优先事项。最初,将优先考虑建立信息学基础设施框架和执行较小的试点项目,更大的目标是在此基础上,随着时间的推移,在更广泛的范围内更好地了解罕见疾病研究和医疗保健。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

REID SIMON其他文献

REID SIMON的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

相似国自然基金

Molecular Interaction Reconstruction of Rheumatoid Arthritis Therapies Using Clinical Data
  • 批准号:
    31070748
  • 批准年份:
    2010
  • 资助金额:
    34.0 万元
  • 项目类别:
    面上项目

相似海外基金

Educational-Clinical Linkage to Improve Health Equity for Children with Developmental Delays and Disabilities from Marginalized Communities
教育与临床联系可改善边缘化社区发育迟缓和残疾儿童的健康公平
  • 批准号:
    10835586
  • 财政年份:
    2023
  • 资助金额:
    $ 101.97万
  • 项目类别:
San Francisco Bay Clinical Trial Unit: Expanding COVID-19 Testing in Heavily Impacted Communities in San Francisco
旧金山湾临床试验单位:在旧金山受影响严重的社区扩大 COVID-19 测试
  • 批准号:
    10166243
  • 财政年份:
    2020
  • 资助金额:
    $ 101.97万
  • 项目类别:
Clinical Sociology of an Effective Collaborative System between Schools and Communities
学校与社区有效协作系统的临床社会学
  • 批准号:
    19K20979
  • 财政年份:
    2018
  • 资助金额:
    $ 101.97万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
Addressing Health Disparities among Oklahoma Minority and Rural Communities through Clinical Research Education and Career Development
通过临床研究教育和职业发展解决俄克拉荷马州少数民族和农村社区之间的健康差异
  • 批准号:
    9340335
  • 财政年份:
    2017
  • 资助金额:
    $ 101.97万
  • 项目类别:
Investigating teleconsent to improve clinical research access in remote communities
研究远程同意以改善偏远社区的临床研究机会
  • 批准号:
    9389723
  • 财政年份:
    2017
  • 资助金额:
    $ 101.97万
  • 项目类别:
Addressing Health Disparities among Oklahoma Minority and Rural Communities through Clinical Research Education and Career Development
通过临床研究教育和职业发展解决俄克拉荷马州少数民族和农村社区之间的健康差异
  • 批准号:
    10202392
  • 财政年份:
    2017
  • 资助金额:
    $ 101.97万
  • 项目类别:
Novel interventions to address methamphetamines in Aboriginal communities, including a randomised trial of a web based therapeutic tool used to treat dependence in clinical settings.
针对原住民社区甲基苯丙胺问题的新颖干预措施,包括对用于治疗临床环境中的依赖的基于网络的治疗工具的随机试验。
  • 批准号:
    nhmrc : 1100696
  • 财政年份:
    2016
  • 资助金额:
    $ 101.97万
  • 项目类别:
    Project Grants
Novel interventions to address methamphetamines in Aboriginal communities, including a randomised trial of a web based therapeutic tool used to treat dependence in clinical settings.
针对原住民社区甲基苯丙胺问题的新颖干预措施,包括对用于治疗临床环境中的依赖的基于网络的治疗工具的随机试验。
  • 批准号:
    nhmrc : GNT1100696
  • 财政年份:
    2016
  • 资助金额:
    $ 101.97万
  • 项目类别:
    Project Grants
InfoMediator: Weaving Clinical Expertise in Online Health Communities
InfoMediator:在在线健康社区中编织临床专业知识
  • 批准号:
    8759393
  • 财政年份:
    2014
  • 资助金额:
    $ 101.97万
  • 项目类别:
West Virginia Clinical and Translational Science Institute: A Statewide Organization Building Research Excellence and Engaging Communities to Improve Health
西弗吉尼亚州临床和转化科学研究所:全州范围内的组织,致力于打造卓越研究并吸引社区改善健康
  • 批准号:
    10685808
  • 财政年份:
    2012
  • 资助金额:
    $ 101.97万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了